关注
Mathieu BLOT
Mathieu BLOT
Infectious Diseases Department, University Hospital, DIJON; INSERM UMR 1231.
在 chu-dijon.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
L Piroth, J Cottenet, AS Mariet, P Bonniaud, M Blot, P Tubert-Bitter, ...
The Lancet Respiratory Medicine 9 (3), 251-259, 2021
5832021
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled …
F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ...
The Lancet infectious diseases 22 (2), 209-221, 2022
3652022
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Infection 49 (5), 889-905, 2021
862021
CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
M Blot, M Jacquier, LS Aho Glele, G Beltramo, M Nguyen, P Bonniaud, ...
Critical Care 24, 1-15, 2020
852020
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
M Blot, JB Bour, JP Quenot, A Bourredjem, M Nguyen, J Guy, S Monier, ...
Journal of translational medicine 18, 1-14, 2020
692020
The value of open-source clinical science in pandemic response: lessons from ISARIC
A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ...
The Lancet infectious diseases 21 (12), 1623-1624, 2021
372021
Isolated anti-HBc: significance and management
F Moretto, FX Catherine, C Esteve, M Blot, L Piroth
Journal of clinical medicine 9 (1), 202, 2020
372020
Comparative review of imipenem/cilastatin versus meropenem
A Salmon-Rousseau, C Martins, M Blot, M Buisson, S Mahy, P Chavanet, ...
Médecine et Maladies Infectieuses 50 (4), 316-322, 2020
352020
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients
Y Yazdanpanah, French COVID Cohort Investigators and Study Group, ...
Journal of Medical Virology 93 (4), 2149-2159, 2021
332021
Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?
F Moretto, T Sixt, H Devilliers, M Abdallahoui, I Eberl, T Rogier, M Buisson, ...
International journal of infectious diseases 105, 256-260, 2021
312021
Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19?
M Blot, D Masson, M Nguyen, A Bourredjem, C Binquet, L Piroth
International Journal of Obesity 45 (9), 2126-2131, 2021
282021
A leukocyte score to improve clinical outcome predictions in bacteremic pneumococcal pneumonia in adults
M Blot, D Croisier, A Péchinot, A Vagner, A Putot, A Fillion, N Baudouin, ...
Open forum infectious diseases 1 (2), ofu075, 2014
282014
Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative database
T Maitre, J Cottenet, G Beltramo, M Georges, M Blot, L Piroth, P Bonniaud, ...
European Respiratory Journal 52 (3), 2018
272018
Mitochondrial alarmins are tissue mediators of ventilator-induced lung injury and ARDS
S Grazioli, I Dunn-Siegrist, LA Pauchard, M Blot, PE Charles, J Pugin
PloS one 14 (11), e0225468, 2019
252019
High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia
M Nguyen, A Bourredjem, L Piroth, B Bouhemad, A Jalil, G Pallot, ...
Scientific Reports 11 (1), 10824, 2021
242021
Alveolar SARS-CoV-2 viral load is tightly correlated with severity in COVID-19 ARDS
M Blot, M Jacquier, C Manoha, L Piroth, PE Charles
Clinical Infectious Diseases 72 (9), e446-e447, 2021
232021
How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed?
C Esteve, FX Catherine, P Chavanet, M Blot, L Piroth
Medecine et maladies infectieuses 50 (8), 633-638, 2020
192020
Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia
M Blot, P Boyer, M Samson, S Audia, H Devilliers, V Leguy, S Berthier, ...
European Journal of Internal Medicine 25 (9), 837-842, 2014
182014
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, F Mentré, ...
The Lancet Infectious Diseases 22 (6), 764-765, 2022
162022
Vitamin D supplementation, bone turnover, and inflammation in HIV-infected patients
L Benguella, A Arbault, A Fillion, M Blot, C Piroth, D Denimal, L Duvillard, ...
Medecine et maladies infectieuses 48 (7), 449-456, 2018
142018
系统目前无法执行此操作,请稍后再试。
文章 1–20